{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["HET-CAM test", "bimatoprost", "central composite design", "glaucoma", "solid lipid nanoparticles (SLNs)"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37513913", "DateRevised": {"Year": "2023", "Month": "08", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "07", "Day": "13"}], "Language": ["eng"], "ELocationID": ["1001", "10.3390/ph16071001"], "Journal": {"ISSN": "1424-8247", "JournalIssue": {"Volume": "16", "Issue": "7", "PubDate": {"Year": "2023", "Month": "Jul", "Day": "13"}}, "Title": "Pharmaceuticals (Basel, Switzerland)", "ISOAbbreviation": "Pharmaceuticals (Basel)"}, "ArticleTitle": "Ocular Delivery of Bimatoprost-Loaded Solid Lipid Nanoparticles for Effective Management of Glaucoma.", "Abstract": {"AbstractText": ["Glaucoma is a progressive optic neuropathy characterized by a rise in the intraocular pressure (IOP) leading to optic nerve damage. Bimatoprost is a prostaglandin analogue used to reduce the elevated IOP in patients with glaucoma. The currently available dosage forms for Bimatoprost suffer from relatively low ocular bioavailability. The objective of this study was to fabricate and optimize solid lipid nanoparticles (SLNs) containing Bimatoprost for ocular administration for the management of glaucoma. Bimatoprost-loaded SLNs were fabricated by solvent evaporation/ultrasonication technique. Glyceryl Monostearate (GMS) was adopted as solid lipid and poloxamer 407 as surfactant. Optimization of SLNs was conducted by central composite design. The optimized formulation was assessed for average particle size, entrapment efficiency (%), zeta potential, surface morphology, drug release study, sterility test, isotonicity test, Hen's egg test-chorioallantoic membrane (HET-CAM) test and histopathology studies. The optimized Bimatoprost-loaded SLNs formulation had an average size of 183.3 \u00b1 13.3 nm, zeta potential of -9.96 \u00b1 1.2 mV, and encapsulation efficiency percentage of 71.8 \u00b1 1.1%. Transmission electron microscopy (TEM) study revealed the nearly smooth surface of formulated particles with a nano-scale size range. In addition, SLNs significantly sustained Bimatoprost release for up to 12 h, compared to free drug (<i>p</i> < 005). Most importantly, HET-CAM test nullified the irritancy of the formulation was verified its tolerability upon ocular use, as manifested by a significant reduction in mean irritation score, compared to positive control (1% sodium dodecyl sulfate; <i>p</i> < 0.001). Histopathology study inferred the absence of any signs of cornea tissue damage upon treatment with Bimatoprost optimized formulation. Collectively, it was concluded that SLNs might represent a viable vehicle for enhancing the corneal permeation and ocular bioavailability of Bimatoprost for the management of glaucoma."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, NGSM Institute of Pharmaceutical Sciences, Nitte (Deemed to be University), Mangalore 575018, India."}], "LastName": "Satyanarayana", "ForeName": "Sandeep Divate", "Initials": "SD"}, {"Identifier": ["0000-0001-7385-868X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt."}, {"Identifier": [], "Affiliation": "Department of Pharmaceutics, College of Pharmacy, University of Hail, Hail 81442, Saudi Arabia."}], "LastName": "Abu Lila", "ForeName": "Amr Selim", "Initials": "AS"}, {"Identifier": ["0000-0002-3902-1162"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, College of Pharmacy, University of Hail, Hail 81442, Saudi Arabia."}], "LastName": "Moin", "ForeName": "Afrasim", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-kharj 11942, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Microbiology and Parasitology, Medicinal and Aromatic Plants Research Institute, National Center for Research, Khartoum 2404, Sudan."}], "LastName": "Moglad", "ForeName": "Ehssan H", "Initials": "EH"}, {"Identifier": ["0000-0002-3741-0893"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-kharj 11942, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt."}], "LastName": "Khafagy", "ForeName": "El-Sayed", "Initials": "ES"}, {"Identifier": ["0000-0003-2821-9373"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah Bint Abdul Rahman University, Riyadh 11671, Saudi Arabia."}], "LastName": "Alotaibi", "ForeName": "Hadil Faris", "Initials": "HF"}, {"Identifier": ["0000-0002-7532-6318"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia."}], "LastName": "Obaidullah", "ForeName": "Ahmad J", "Initials": "AJ"}, {"Identifier": ["0000-0002-4404-0296"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutics, NGSM Institute of Pharmaceutical Sciences, Nitte (Deemed to be University), Mangalore 575018, India."}], "LastName": "Charyulu", "ForeName": "Rompicherla Narayana", "Initials": "RN"}], "GrantList": [{"GrantID": "PSAU/2023/R/1444", "Agency": "Prince Sattam Bin Abdulaziz University", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceuticals (Basel)", "NlmUniqueID": "101238453", "ISSNLinking": "1424-8247"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Januleviciene I., Siaudvytyte L., Barsauskaite R. Ophthalmic drug delivery in glaucoma\u2014A review. Pharmaceutics. 2012;4:243\u2013251. doi: 10.3390/pharmaceutics4010243.", "ArticleIdList": ["10.3390/pharmaceutics4010243", "PMC3834898", "24300191"]}, {"Citation": "Weinreb R.N., Aung T., Medeiros F.A. The pathophysiology and treatment of glaucoma: A review. JAMA. 2014;311:1901\u20131911. doi: 10.1001/jama.2014.3192.", "ArticleIdList": ["10.1001/jama.2014.3192", "PMC4523637", "24825645"]}, {"Citation": "Plosker G.L., Keam S.J. Bimatoprost: A pharmacoeconomic review of its use in open-angle glaucoma and ocular hypertension. Pharmacoeconomics. 2006;24:297\u2013314. doi: 10.2165/00019053-200624030-00010.", "ArticleIdList": ["10.2165/00019053-200624030-00010", "16519552"]}, {"Citation": "Lee D., Mantravadi A.V., Myers J.S. Patient considerations in ocular hypertension: Role of bimatoprost ophthalmic solution. Clin. Ophthalmol. 2017;11:1273\u20131280. doi: 10.2147/OPTH.S118689.", "ArticleIdList": ["10.2147/OPTH.S118689", "PMC5513827", "28744094"]}, {"Citation": "Cantor L.B. Bimatoprost: A member of a new class of agents, the prostamides, for glaucoma management. Expert. Opin. Investig. Drugs. 2001;10:721\u2013731. doi: 10.1517/13543784.10.4.721.", "ArticleIdList": ["10.1517/13543784.10.4.721", "11281821"]}, {"Citation": "Jha A.K., Sarkar R., Udayan U.K., Roy P.K., Chaudhary R.K.P. Bimatoprost in Dermatology. Indian Dermatol. Online J. 2018;9:224\u2013228. doi: 10.4103/idoj.IDOJ_62_16.", "ArticleIdList": ["10.4103/idoj.IDOJ_62_16", "PMC5956885", "29854658"]}, {"Citation": "Brubaker R.F. Mechanism of Action of Bimatoprost (Lumigan\u2122) Surv. Ophthalmol. 2001;45:S347\u2013S351. doi: 10.1016/S0039-6257(01)00213-2.", "ArticleIdList": ["10.1016/S0039-6257(01)00213-2", "11434937"]}, {"Citation": "Patil A.J., Vajaranant T.S., Edward D.P. Bimatoprost\u2014A review. Expert. Opin. Pharmacother. 2009;10:2759\u20132768. doi: 10.1517/14656560903292649.", "ArticleIdList": ["10.1517/14656560903292649", "19874254"]}, {"Citation": "Wadetwar R.N., Agrawal A.R., Kanojiya P.S. In situ gel containing Bimatoprost solid lipid nanoparticles for ocular delivery: In-vitro and ex-vivo evaluation. J. Drug Deliv. Sci. Technol. 2020;56:101575. doi: 10.1016/j.jddst.2020.101575.", "ArticleIdList": ["10.1016/j.jddst.2020.101575"]}, {"Citation": "Lambert W.S., Carlson B.J., van der Ende A.E., Shih G., Dobish J.N., Calkins D.J., Harth E.A. Nanosponge-Mediated Drug Delivery Lowers Intraocular Pressure. Transl. Vis. Sci. Technol. 2015;4:1. doi: 10.1167/tvst.4.1.1.", "ArticleIdList": ["10.1167/tvst.4.1.1", "PMC4294067", "25599009"]}, {"Citation": "Franca J.R., Foureaux G., Fuscaldi L.L., Ribeiro T.G., Rodrigues L.B., Bravo R., Castilho R.O., Yoshida M.I., Cardoso V.N., Fernandes S.O., et al. Bimatoprost-loaded ocular inserts as sustained release drug delivery systems for glaucoma treatment: In vitro and in vivo evaluation. PLoS ONE. 2014;9:e95461. doi: 10.1371/journal.pone.0095461.", "ArticleIdList": ["10.1371/journal.pone.0095461", "PMC4005758", "24788066"]}, {"Citation": "Seal J.R., Robinson M.R., Burke J., Bejanian M., Coote M., Attar M. Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target Tissues. J. Ocul. Pharmacol. Ther. 2019;35:50\u201357. doi: 10.1089/jop.2018.0067.", "ArticleIdList": ["10.1089/jop.2018.0067", "PMC6354606", "30335560"]}, {"Citation": "Gaudana R., Ananthula H.K., Parenky A., Mitra A.K. Ocular drug delivery. AAPS J. 2010;12:348\u2013360. doi: 10.1208/s12248-010-9183-3.", "ArticleIdList": ["10.1208/s12248-010-9183-3", "PMC2895432", "20437123"]}, {"Citation": "Agrahari V., Mandal A., Trinh H.M., Joseph M., Ray A., Hadji H., Mitra R., Pal D., Mitra A.K. A comprehensive insight on ocular pharmacokinetics. Drug Deliv. Transl. Res. 2016;6:735\u2013754. doi: 10.1007/s13346-016-0339-2.", "ArticleIdList": ["10.1007/s13346-016-0339-2", "PMC5319401", "27798766"]}, {"Citation": "Tasharrofi N., Nourozi M., Marzban A. How liposomes pave the way for ocular drug delivery after topical administration. J. Drug Deliv. Sci. Technol. 2022;67:103045. doi: 10.1016/j.jddst.2021.103045.", "ArticleIdList": ["10.1016/j.jddst.2021.103045"]}, {"Citation": "Omerovi\u0107 N., Vrani\u0107 E. Application of nanoparticles in ocular drug delivery systems. Health Technol. 2020;10:61\u201378. doi: 10.1007/s12553-019-00381-w.", "ArticleIdList": ["10.1007/s12553-019-00381-w"]}, {"Citation": "Wu Y., Liu Y., Li X., Kebebe D., Zhang B., Ren J., Lu J., Li J., Du S., Liu Z. Research progress of in-situ gelling ophthalmic drug delivery system. Asian J. Pharm. Sci. 2019;14:1\u201315. doi: 10.1016/j.ajps.2018.04.008.", "ArticleIdList": ["10.1016/j.ajps.2018.04.008", "PMC7032175", "32104434"]}, {"Citation": "Seyfoddin A., Shaw J., Al-Kassas R. Solid lipid nanoparticles for ocular drug delivery. Drug Deliv. 2010;17:467\u2013489. doi: 10.3109/10717544.2010.483257.", "ArticleIdList": ["10.3109/10717544.2010.483257", "20491540"]}, {"Citation": "Seyfoddin A., Al-Kassas R. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir. Drug. Dev. Ind. Pharm. 2013;39:508\u2013519. doi: 10.3109/03639045.2012.665460.", "ArticleIdList": ["10.3109/03639045.2012.665460", "22424312"]}, {"Citation": "Battaglia L., Serpe L., Foglietta F., Muntoni E., Gallarate M., Del Pozo Rodriguez A., Solinis M.A. Application of lipid nanoparticles to ocular drug delivery. Expert Opin. Drug. Deliv. 2016;13:1743\u20131757. doi: 10.1080/17425247.2016.1201059.", "ArticleIdList": ["10.1080/17425247.2016.1201059", "27291069"]}, {"Citation": "Khames A., Khaleel M.A., El-Badawy M.F., El-Nezhawy A.O.H. Natamycin solid lipid nanoparticles\u2014Sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: Preparation and optimization. Int. J. Nanomed. 2019;14:2515\u20132531. doi: 10.2147/IJN.S190502.", "ArticleIdList": ["10.2147/IJN.S190502", "PMC6459158", "31040672"]}, {"Citation": "Kaur I.P., Kanwar M. Ocular preparations: The formulation approach. Drug Dev. Ind. Pharm. 2002;28:473\u2013493. doi: 10.1081/DDC-120003445.", "ArticleIdList": ["10.1081/DDC-120003445", "12098838"]}, {"Citation": "Dong Y., Ng W.K., Shen S., Kim S., Tan R.B.H. Solid lipid nanoparticles: Continuous and potential large-scale nanoprecipitation production in static mixers. Colloids Surf. B Biointerfaces. 2012;94:68\u201372. doi: 10.1016/j.colsurfb.2012.01.018.", "ArticleIdList": ["10.1016/j.colsurfb.2012.01.018", "22326649"]}, {"Citation": "Jiang S., Franco Y.L., Zhou Y., Chen J. Nanotechnology in retinal drug delivery. Int. J. Ophthalmol. 2018;11:1038\u20131044. doi: 10.18240/ijo.2018.06.23.", "ArticleIdList": ["10.18240/ijo.2018.06.23", "PMC6010371", "29977820"]}, {"Citation": "Tiwari S., Mistry P.K., Patel V. SLNs Based on Co-Processed Lipids for Topical Delivery of Terbinafine Hydrochloride. J. Pharm. Drug Dev. 2014;2:604."}, {"Citation": "Reddy L.H., Vivek K., Bakshi N., Murthy R.S. Tamoxifen citrate loaded solid lipid nanoparticles (SLN): Preparation, characterization, in vitro drug release, and pharmacokinetic evaluation. Pharm. Dev. Technol. 2006;11:167\u2013177. doi: 10.1080/10837450600561265.", "ArticleIdList": ["10.1080/10837450600561265", "16749527"]}, {"Citation": "Emami J., Mohiti H., Hamishehkar H., Varshosaz J. Formulation and optimization of solid lipid nanoparticle formulation for pulmonary delivery of budesonide using Taguchi and Box-Behnken design. Res. Pharm. Sci. 2015;10:17\u201333.", "ArticleIdList": ["PMC4578209", "26430454"]}, {"Citation": "Shah M., Pathak K. Development and statistical optimization of solid lipid nanoparticles of simvastatin by using 2(3) full-factorial design. AAPS PharmSciTech. 2010;11:489\u2013496. doi: 10.1208/s12249-010-9414-z.", "ArticleIdList": ["10.1208/s12249-010-9414-z", "PMC2902350", "20309652"]}, {"Citation": "Yang Y.Y., Chung T.S., Bai X.-L., Chan W.K. Effect of preparation conditions on morphology and release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion method. Chem. Eng. Sci. 2000;55:2223\u20132236. doi: 10.1016/S0009-2509(99)00503-5.", "ArticleIdList": ["10.1016/S0009-2509(99)00503-5"]}, {"Citation": "Nair A.B., Shah J., Al-Dhubiab B.E., Jacob S., Patel S.S., Venugopala K.N., Morsy M.A., Gupta S., Attimarad M., Sreeharsha N., et al. Clarithromycin Solid Lipid Nanoparticles for Topical Ocular Therapy: Optimization, Evaluation and In Vivo Studies. Pharmaceutics. 2021;13:523. doi: 10.3390/pharmaceutics13040523.", "ArticleIdList": ["10.3390/pharmaceutics13040523", "PMC8068826", "33918870"]}, {"Citation": "Ara\u00fajo J., Gonzalez-Mira E., Egea M.A., Garcia M.L., Souto E.B. Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications. Int. J. Pharm. 2010;393:167\u2013175. doi: 10.1016/j.ijpharm.2010.03.034.", "ArticleIdList": ["10.1016/j.ijpharm.2010.03.034", "20362042"]}, {"Citation": "Al Hagbani T., Rizvi S.M.D., Hussain T., Mehmood K., Rafi Z., Moin A., Abu Lila A.S., Alshammari F., Khafagy E.S., Rahamathulla M., et al. Cefotaxime Mediated Synthesis of Gold Nanoparticles: Characterization and Antibacterial Activity. Polymers. 2022;14:771. doi: 10.3390/polym14040771.", "ArticleIdList": ["10.3390/polym14040771", "PMC8875691", "35215685"]}, {"Citation": "Baranowski P., Karolewicz B., Gajda M., Pluta J. Ophthalmic drug dosage forms: Characterisation and research methods. Sci. World J. 2014;2014:861904. doi: 10.1155/2014/861904.", "ArticleIdList": ["10.1155/2014/861904", "PMC3977496", "24772038"]}, {"Citation": "Vinardell M.P., Maci\u00e1n M. Comparative study of the HET-CAM test and the Draize eye test for assessment of irritancy potential. Toxicol. Vitr. 1994;8:467\u2013470. doi: 10.1016/0887-2333(94)90170-8.", "ArticleIdList": ["10.1016/0887-2333(94)90170-8", "20692940"]}, {"Citation": "Tavaszi J., Budai P. The use of HET-CAM test in detecting the ocular irritation. Commun. Agric. Appl. Biol. Sci. 2007;72:137\u2013141.", "ArticleIdList": ["18399434"]}, {"Citation": "Moin A., Wani S.U.D., Osmani R.A., Abu Lila A.S., Khafagy E.S., Arab H.H., Gangadharappa H.V., Allam A.N. Formulation, characterization, and cellular toxicity assessment of tamoxifen-loaded silk fibroin nanoparticles in breast cancer. Drug Deliv. 2021;28:1626\u20131636. doi: 10.1080/10717544.2021.1958106.", "ArticleIdList": ["10.1080/10717544.2021.1958106", "PMC8330732", "34328806"]}, {"Citation": "Duong V.A., Nguyen T.T., Maeng H.J. Preparation of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Drug Delivery and the Effects of Preparation Parameters of Solvent Injection Method. Molecules. 2020;25:4781. doi: 10.3390/molecules25204781.", "ArticleIdList": ["10.3390/molecules25204781", "PMC7587569", "33081021"]}, {"Citation": "K\u00fc\u00e7\u00fckt\u00fcrkmen B., \u00d6z U.C., Bozkir A. In Situ Hydrogel Formulation for Intra-Articular Application of Diclofenac Sodium-Loaded Polymeric Nanoparticles. Turk. J. Pharm. Sci. 2017;14:56\u201364. doi: 10.4274/tjps.84803.", "ArticleIdList": ["10.4274/tjps.84803", "PMC7227994", "32454595"]}, {"Citation": "Dorraj G., Moghimi H.R. Preparation of SLN-containing Thermoresponsive In-Situ Forming Gel as a Controlled Nanoparticle Delivery System and Investigating its Rheological, Thermal and Erosion Behavior. Iran. J. Pharm. Res. 2015;14:347\u2013358.", "ArticleIdList": ["PMC4403051", "25901142"]}, {"Citation": "Abu Lila A.S., Amran M., Tantawy M.A., Moglad E.H., Gad S., Alotaibi H.F., Obaidullah A.J., Khafagy E.-S. In Vitro Cytotoxicity and In Vivo Antitumor Activity of Lipid Nanocapsules Loaded with Novel Pyridine Derivatives. Pharmaceutics. 2023;15:1755. doi: 10.3390/pharmaceutics15061755.", "ArticleIdList": ["10.3390/pharmaceutics15061755", "PMC10304225", "37376202"]}, {"Citation": "Khafagy E.S., Abu Lila A.S., Sallam N.M., Sanad R.A., Ahmed M.M., Ghorab M.M., Alotaibi H.F., Alalaiwe A., Aldawsari M.F., Alshahrani S.M., et al. Preparation and Characterization of a Novel Mucoadhesive Carvedilol Nanosponge: A Promising Platform for Buccal Anti-Hypertensive Delivery. Gels. 2022;8:235. doi: 10.3390/gels8040235.", "ArticleIdList": ["10.3390/gels8040235", "PMC9028337", "35448136"]}, {"Citation": "Aldawsari M.F., Khafagy E.S., Alotaibi H.F., Abu Lila A.S. Vardenafil-Loaded Bilosomal Mucoadhesive Sponge for Buccal Delivery: Optimization, Characterization, and In Vivo Evaluation. Polymers. 2022;14:4184. doi: 10.3390/polym14194184.", "ArticleIdList": ["10.3390/polym14194184", "PMC9573218", "36236132"]}, {"Citation": "Khalil R.M., Abd-Elbary A., Kassem M.A., Ghorab M.M., Basha M. Nanostructured lipid carriers (NLCs) versus solid lipid nanoparticles (SLNs) for topical delivery of meloxicam. Pharm. Dev. Technol. 2014;19:304\u2013314. doi: 10.3109/10837450.2013.778872.", "ArticleIdList": ["10.3109/10837450.2013.778872", "23528038"]}, {"Citation": "Shanmugam S., Valarmathi S., Kumars S. Sterility Testing Procedure of Ophthalmic Ocusert Aciclovir Used for Treating Herpes Simplex Virus. Asian J. Pharm. Clin. Res. 2017;10:344\u2013346."}, {"Citation": "Kurniawansyah I.S., Rusdiana T., Abnaz Z.D., Sopyan I., Subarnas A. Study of Isotonicity and Ocular Irritation of Chloramphenicol in situ Gel. Int. J. Appl. Pharm. 2021;13:103\u2013107. doi: 10.22159/ijap.2021v13i1.39925.", "ArticleIdList": ["10.22159/ijap.2021v13i1.39925"]}, {"Citation": "Wilson S.L., Ahearne M., Hopkinson A. An overview of current techniques for ocular toxicity testing. Toxicology. 2015;327:32\u201346. doi: 10.1016/j.tox.2014.11.003.", "ArticleIdList": ["10.1016/j.tox.2014.11.003", "25445805"]}, {"Citation": "Zubairu Y., Negi L.M., Iqbal Z., Talegaonkar S. Design and development of novel bioadhesive niosomal formulation for the transcorneal delivery of anti-infective agent: In-vitro and ex-vivo investigations. Asian J. Pharm. Sci. 2015;10:322\u2013330. doi: 10.1016/j.ajps.2015.02.001.", "ArticleIdList": ["10.1016/j.ajps.2015.02.001"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "6", "Day": "6"}, {"Year": "2023", "Month": "7", "Day": "7"}, {"Year": "2023", "Month": "7", "Day": "11"}, {"Year": "2023", "Month": "7", "Day": "29", "Hour": "11", "Minute": "44"}, {"Year": "2023", "Month": "7", "Day": "29", "Hour": "11", "Minute": "43"}, {"Year": "2023", "Month": "7", "Day": "29", "Hour": "1", "Minute": "38"}, {"Year": "2023", "Month": "7", "Day": "13"}], "PublicationStatus": "epublish", "ArticleIdList": ["37513913", "PMC10385266", "10.3390/ph16071001", "ph16071001"]}}], "PubmedBookArticle": []}